Bahl & Gaynor’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-11,300
| Closed | -$218K | – | 397 |
|
2016
Q3 | $218K | Sell |
11,300
-100
| -0.9% | -$1.93K | ﹤0.01% | 379 |
|
2016
Q2 | $222K | Hold |
11,400
| – | – | ﹤0.01% | 385 |
|
2016
Q1 | $235K | Hold |
11,400
| – | – | ﹤0.01% | 386 |
|
2015
Q4 | $234K | Hold |
11,400
| – | – | ﹤0.01% | 395 |
|
2015
Q3 | $195K | Sell |
11,400
-4,900
| -30% | -$83.8K | ﹤0.01% | 418 |
|
2015
Q2 | $304K | Hold |
16,300
| – | – | ﹤0.01% | 387 |
|
2015
Q1 | $311K | Sell |
16,300
-5,630
| -26% | -$107K | ﹤0.01% | 372 |
|
2014
Q4 | $361K | Sell |
21,930
-12,560
| -36% | -$207K | 0.01% | 337 |
|
2014
Q3 | $610K | Sell |
34,490
-10,678
| -24% | -$189K | 0.01% | 262 |
|
2014
Q2 | $932K | Sell |
45,168
-37,109
| -45% | -$766K | 0.01% | 217 |
|
2014
Q1 | $1.79M | Sell |
82,277
-2,055
| -2% | -$44.8K | 0.03% | 175 |
|
2013
Q4 | $2.24M | Sell |
84,332
-4,285
| -5% | -$114K | 0.04% | 162 |
|
2013
Q3 | $2.09M | Sell |
88,617
-2,590
| -3% | -$61.2K | 0.04% | 160 |
|
2013
Q2 | $1.96M | Buy |
+91,207
| New | +$1.96M | 0.04% | 156 |
|